Cargando…
TACI Expression and Signaling in Chronic Lymphocytic Leukemia
TACI is a membrane receptor of BAFF and APRIL, contributing to the differentiation and survival of normal B cells. Although malignant B cells are also subjected on TACI signaling, there is a remarkable intradisease and interindividual variability of TACI expression in B-cell malignancies. The aim of...
Autores principales: | Mamara, Antigoni, Germenis, Anastasios E., Kompoti, Maria, Palassopoulou, Maria, Mandala, Eudokia, Banti, Anastasia, Giannakoulas, Nikolaos, Speletas, Matthaios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408744/ https://www.ncbi.nlm.nih.gov/pubmed/25950010 http://dx.doi.org/10.1155/2015/478753 |
Ejemplares similares
-
PB1855: LACK OF MUTATIONS IN TNFRSF13B (TACI) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
por: Giannakoulas, N., et al.
Publicado: (2022) -
Heterozygous Alterations of TNFRSF13B/TACI in Tonsillar Hypertrophy and Sarcoidosis
por: Speletas, Matthaios, et al.
Publicado: (2013) -
Identification of a STAT5 Target Gene, Dpf3, Provides Novel Insights in Chronic Lymphocytic Leukemia
por: Theodorou, Marina, et al.
Publicado: (2013) -
Transient ischemic attacks as the first presentation of JAK2-V617F positive chronic myeloproliferative neoplasm
por: Kalala, Fani, et al.
Publicado: (2012) -
BAFF/APRIL System Is Functional in B-Cell Acute Lymphoblastic Leukemia in a Disease Subtype Manner
por: Sevdali, Eirini, et al.
Publicado: (2019)